Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 8/20 | 0.41 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.32 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20162695 | 0.89 | CFTR (0.41) | CFTRDYRK1BGRM4KMT2ATP53 | |
| SCHEMBL20162913 | 0.79 | CFTR (0.50) | CFTRRETKDRSRC | |
| SCHEMBL20182174 | 0.77 | DRD2 (0.40) | CFTRDYRK1BGRM4KMT2ATP53 | |
| SCHEMBL20162789 | 0.74 | CFTR (0.62) | CFTRKDRSRC | |
| SCHEMBL20162980 | 0.74 | CFTR (0.53) | CFTRRETKDRSRC | |
| SCHEMBL30037534 | 0.74 | CFTR (0.53) | CFTRRETKDRSRC | |
| SCHEMBL20181875 | 0.73 | RET (0.34) | KMT2AMEN1NR2F2ADKRET | |
| SCHEMBL14947692 | 0.71 | GRM4 (0.43) | CFTRDYRK1BGRM4MTOR | |
| SCHEMBL30037632 | 0.71 | CFTR (0.40) | CFTRKMT2AHPGDADKRET | |
| SCHEMBL20162783 | 0.71 | CFTR (0.40) | CFTRKMT2AHPGDADKRET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018094137-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) | 2018-05-24 | — | — | WO | disclosed |